Literature DB >> 10440964

The effect of residual Nyquist ghost in quantitative echo-planar diffusion imaging.

D A Porter1, F Calamante, D G Gadian, A Connelly.   

Abstract

Single-shot diffusion-weighted echo-planar imaging (EPI) is typically used for most clinical diffusion studies due to its low sensitivity to patient motion. Although the Nyquist ghost artifact in EPI can be substantially reduced, there is frequently a residual ghost with low signal intensity. As reported in this study, this residual ghost can produce severe artifacts when maps of the apparent diffusion coefficient (ADC) are calculated from single-shot echo-planar images. The artifacts presented in this paper appear as regions of apparently low ADC which simulate regions of reduced diffusion, but are in fact generated by b-value dependent Nyquist ghosts of the orbits. Data acquired in vivo were used to demonstrate that these artifacts can be avoided by including standard methods of spatial presaturation or fluid-suppression in the diffusion-weighted EPI protocol. In addition, phantom studies were used to illustrate how phase and amplitude variations in the ghost generate the artifacts and theoretical expressions, derived elsewhere, were used to provide a detailed understanding of the artifacts observed in vivo. The level of Nyquist ghost reported for the current generation of commercial scanners suggests that this is a general phenomenon which should be a consideration in all EPI-based diffusion studies. Magn Reson Med 42:385-392, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10440964     DOI: 10.1002/(sici)1522-2594(199908)42:2<385::aid-mrm21>3.0.co;2-j

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  8 in total

1.  Influence of selecting EPI readout-encoding bandwidths on arterial spin labeling perfusion MRI.

Authors:  Geon-Ho Jahng; Norbert Schuff
Journal:  MAGMA       Date:  2009-07-04       Impact factor: 2.310

2.  Diffusion anisotropy indexes are sensitive to selecting the EPI readout-encoding bandwidth at high-field MRI.

Authors:  Geon-Ho Jahng; Michael W Weiner; Norbert Schuff
Journal:  Magn Reson Imaging       Date:  2008-06       Impact factor: 2.546

3.  A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiforme.

Authors:  M J Paldino; A Desjardins; H S Friedman; J J Vredenburgh; D P Barboriak
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

Review 4.  What's new and what's next in diffusion MRI preprocessing.

Authors:  Chantal M W Tax; Matteo Bastiani; Jelle Veraart; Eleftherios Garyfallidis; M Okan Irfanoglu
Journal:  Neuroimage       Date:  2021-12-26       Impact factor: 7.400

5.  Diffusion-weighted single-shot echo planar MR imaging of normal human prostate using different b values.

Authors:  Haojun Shi; Xiangquan Kong; Gansheng Feng; Haibo Xu; Dingxi Liu; Qun Yu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24

6.  Characterization of Nyquist ghost in EPI-fMRI acquisition sequences implemented on two clinical 1.5 T MR scanner systems: effect of readout bandwidth and echo spacing.

Authors:  Marco Giannelli; Stefano Diciotti; Carlo Tessa; Mario Mascalchi
Journal:  J Appl Clin Med Phys       Date:  2010-07-12       Impact factor: 2.102

7.  Longitudinal In Vivo Diffusion Magnetic Resonance Imaging Remote from the Lesion Site in Rat Spinal Cord Injury.

Authors:  Alice Motovylyak; Nathan P Skinner; Brian D Schmit; Natasha Wilkins; Shekar N Kurpad; Matthew D Budde
Journal:  J Neurotrauma       Date:  2018-11-19       Impact factor: 4.869

8.  Bladder cancer: detection and image quality compared among iShim, RESOLVE, and ss-EPI diffusion-weighted MR imaging with high b value at 3.0 T MRI.

Authors:  Hongyi Li; Lin Liu; Qinglei Shi; Alto Stemmer; Hong Zeng; Yi Li; Mengchao Zhang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.